Cabot - CBT Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CBT shares.
View CBT analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued 12-month target prices for Cabot's shares. Their CBT share price forecasts range from $72.00 to $90.00. On average, they anticipate the company's stock price to reach $82.33 in the next year. This suggests a possible upside of 11.8% from the stock's current price.
View analysts price targets for CBT or view top-rated stocks among Wall Street analysts.

Cabot's stock was trading at $56.20 on January 1st, 2022. Since then, CBT shares have increased by 31.0% and is now trading at $73.62.
View the best growth stocks for 2022 here.

Cabot saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 1,190,000 shares, a decline of 16.8% from the October 31st total of 1,430,000 shares. Based on an average daily trading volume, of 355,700 shares, the short-interest ratio is presently 3.3 days. Approximately 2.1% of the company's shares are short sold.
View Cabot's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, January 30th 2023.
View our CBT earnings forecast.

Cabot Co. (NYSE:CBT) released its earnings results on Sunday, November, 7th. The specialty chemicals company reported $1.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.03 by $0.08. The specialty chemicals company earned $904 million during the quarter, compared to analyst estimates of $914.88 million. Cabot had a trailing twelve-month return on equity of 35.30% and a net margin of 4.84%. Cabot's revenue was up 37.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.68 earnings per share.

Cabot declared a quarterly dividend on Thursday, November 10th. Investors of record on Friday, November 25th will be paid a dividend of $0.37 per share on Friday, December 9th. This represents a $1.48 annualized dividend and a dividend yield of 2.01%. The ex-dividend date is Wednesday, November 23rd.
Read our dividend analysis for CBT.

Cabot (NYSE:CBT) pays an annual dividend of $1.48 per share and currently has a dividend yield of 2.03%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 41.11%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CBT will have a dividend payout ratio of 24.38% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CBT.

Cabot updated its FY 2023 earnings guidance on Monday, November, 21st. The company provided earnings per share guidance of $6.25-$6.75 for the period, compared to the consensus estimate of $6.97. The company issued revenue guidance of -.

40 employees have rated Cabot Chief Executive Officer Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among the company's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (12.06%), Vanguard Group Inc. (10.97%), State Street Corp (3.21%), Dimensional Fund Advisors LP (2.84%), Bank of New York Mellon Corp (1.55%) and LSV Asset Management (1.39%). Insiders that own company stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita and Sean D Keohane.
View institutional ownership trends.

Shares of CBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBT stock can currently be purchased for approximately $73.62.

Cabot (NYSE:CBT) has a market capitalization of $4.15 billion and generates $4.32 billion in revenue each year. The specialty chemicals company earns $209 million in net income (profit) each year or $3.60 on an earnings per share basis.

The company employs 4,200 workers across the globe.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The official website for the company is www.cabot-corp.com. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at steve.delahunt@cabotcorp.com, or via fax at 617-342-6103.